Ananda Pharma (AQSE:ANA) LT-Debt-to-Total-Asset : 0.00 (As of Jul. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Ananda Pharma LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Ananda Pharma's long-term debt to total assests ratio for the quarter that ended in Jul. 2024 was 0.00.

Ananda Pharma's long-term debt to total assets ratio stayed the same from Jan. 2023 (0.00) to Jul. 2024 (0.00).

Ananda Pharma LT-Debt-to-Total-Asset Historical Data

The historical data trend for Ananda Pharma's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Pharma LT-Debt-to-Total-Asset Chart

Ananda Pharma Annual Data

Trend

Jan19

Jan20

Jan21

Jan22

Jan23

LT-Debt-to-Total-Asset

0.25

Ananda Pharma Semi-Annual Data
	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23	Jul24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial							0.25	0.18	-	-	-

Ananda Pharma LT-Debt-to-Total-Asset Calculation

Ananda Pharma's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jan. 2023 is calculated as

LT Debt to Total Assets (A: Jan. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Jan. 2023 )	/	Total Assets (A: Jan. 2023 )
	=	0	/	6.509
	=

Ananda Pharma's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jul. 2024 is calculated as

LT Debt to Total Assets (Q: Jul. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jul. 2024 )	/	Total Assets (Q: Jul. 2024 )
	=	0	/	3.26
	=	0.00

Ananda Pharma (AQSE:ANA) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Ananda Pharma LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Ananda Pharma's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Ananda Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Pharma PLC (AQSE:ANA) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.anandapharma.co.uk

Ananda Pharma PLC is focused on the development of cannabinoid therapies for the treatment of a range of complex conditions. The company is developing NHS-approved and MHRA-licensed cannabinoid medicines for the treatment of drug-resistant epilepsies and specific inflammatory pain conditions (starting with CIPN & endometriosis) and HFpEF heart failure.

Ananda Pharma Headlines

No Headlines